Deerfield Management Company, L.P. (Series C) Generation Bio Co. Transaction History

Deerfield Management Company, L.P. (Series C)

$5.38 Billion
Q3 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$24.34 - $38.34 $21.9 Million - $34.4 Million	-897,779 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$24.74 - $40.2 $1.57 Million - $2.55 Million	-63,436 Reduced 6.6%	897,779 $25.6 Million
Q3 2020 Nov 16, 2020	SELL	$18.07 - $31.84 $4.07 Million - $7.16 Million	-225,000 Reduced 18.97%	961,215 $29.7 Million
Q2 2020 Aug 14, 2020	BUY	$20.1 - $24.69 $23.8 Million - $29.3 Million	1,186,215 New	1,186,215 $24.9 Million

Others Institutions Holding GBIO

# of Institutions

Shares Held

49.6M

Call Options Held

Put Options Held

Price T Rowe Associates Inc Baltimore, MD

9.35M
Shares

$12.6 Million
0.0% of portfolio
Atlas Venture Life Science Advisors, LLC

8.28M
Shares

$11.2 Million
2.52% of portfolio
Bellevue Group Ag Kuesnacht, V8

3.92M
Shares

$5.29 Million
0.16% of portfolio
Black Rock Inc. New York, NY

3.29M
Shares

$4.45 Million
0.0% of portfolio
Bank Of America Corp Charlotte, NC

2.98M
Shares

$4.03 Million
0.0% of portfolio

View Full List

About Generation Bio Co.

Ticker GBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,011,200
Market Cap $79.7M
Description
Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was f...

More about GBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deerfield Management Company, L.P. (Series C), based on Form 13F filings with the SEC.

News

Stay updated on Deerfield Management Company, L.P. (Series C) with notifications on news.

Account